Analysis of Pancreatic Cancer Genetic Risk Factors in a Multi-Ethnic Population Sample.

IF 2.1 Q3 ONCOLOGY World Journal of Oncology Pub Date : 2024-10-01 Epub Date: 2024-08-10 DOI:10.14740/wjon1911
Abdullah Al-Qahtani, Ali Al-Ali, Bency John, Kusum Kapila, Rabeah Al-Temaimi
{"title":"Analysis of Pancreatic Cancer Genetic Risk Factors in a Multi-Ethnic Population Sample.","authors":"Abdullah Al-Qahtani, Ali Al-Ali, Bency John, Kusum Kapila, Rabeah Al-Temaimi","doi":"10.14740/wjon1911","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pancreatic cancer (PC) has one of the highest mortality to incidence ratio of all cancers. Early identification of at-risk individuals should permit early diagnosis. Genome-wide association studies showed the association of several genetic variants with PC risk in multi-ethnic populations. Our objective was to examine the association of these genetic variants with PC in a population sample from Kuwait.</p><p><strong>Methods: </strong>DNA samples from 103 pancreatic ductal adenocarcinoma (PDAC) specimens and 132 healthy controls were used for genotyping <i>ABO</i> rs505922, <i>BCAR1</i> rs7190458, <i>LINC-PINT</i> rs6971499, <i>HNF1B</i> rs4795218, <i>VDR</i> rs2228570 rs731236, and <i>PRSS1</i> rs111033565 rs111033568 rs387906698 and rs267606982 using TaqMan genotyping assays, and VDR expression was performed by immunocytochemistry.</p><p><strong>Results: </strong><i>ABO</i> rs505922C and <i>VDR</i> rs2228570A were associated with PDAC risk (odds ratio (OR): 1.55, 95% confidence interval (CI): 1.07 - 2.24, P = 0.027; OR: 1.64, 95% CI: 1.09 - 2.48, P = 0.024; respectively). An unweighted polygenic risk score (<i>ABO</i> rs505922, <i>BCAR1</i> rs7190458, <i>LINC-PINT</i> rs6971499, and <i>HNF1B</i> rs4795218) was significantly associated with PDAC risk (β: -0.11, 95% CI: -0.15 to -0.05, P < 0.001). VDR expression was downregulated or absent in most PDAC specimens regardless of <i>VDR</i> haplotype.</p><p><strong>Conclusion: </strong><i>ABO</i> rs505922C and <i>VDR</i> rs2228570A are PDAC genetic risk factors in our population. Ethnicity influences the association of reported genetic PDAC risk factors and should be adjusted for when performing PDAC genetic risk estimations. Investigation of these genetic risk factors in other ethnic populations is a necessity to evaluate their PDAC risk prediction potential.</p>","PeriodicalId":46797,"journal":{"name":"World Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11424118/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/wjon1911","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pancreatic cancer (PC) has one of the highest mortality to incidence ratio of all cancers. Early identification of at-risk individuals should permit early diagnosis. Genome-wide association studies showed the association of several genetic variants with PC risk in multi-ethnic populations. Our objective was to examine the association of these genetic variants with PC in a population sample from Kuwait.

Methods: DNA samples from 103 pancreatic ductal adenocarcinoma (PDAC) specimens and 132 healthy controls were used for genotyping ABO rs505922, BCAR1 rs7190458, LINC-PINT rs6971499, HNF1B rs4795218, VDR rs2228570 rs731236, and PRSS1 rs111033565 rs111033568 rs387906698 and rs267606982 using TaqMan genotyping assays, and VDR expression was performed by immunocytochemistry.

Results: ABO rs505922C and VDR rs2228570A were associated with PDAC risk (odds ratio (OR): 1.55, 95% confidence interval (CI): 1.07 - 2.24, P = 0.027; OR: 1.64, 95% CI: 1.09 - 2.48, P = 0.024; respectively). An unweighted polygenic risk score (ABO rs505922, BCAR1 rs7190458, LINC-PINT rs6971499, and HNF1B rs4795218) was significantly associated with PDAC risk (β: -0.11, 95% CI: -0.15 to -0.05, P < 0.001). VDR expression was downregulated or absent in most PDAC specimens regardless of VDR haplotype.

Conclusion: ABO rs505922C and VDR rs2228570A are PDAC genetic risk factors in our population. Ethnicity influences the association of reported genetic PDAC risk factors and should be adjusted for when performing PDAC genetic risk estimations. Investigation of these genetic risk factors in other ethnic populations is a necessity to evaluate their PDAC risk prediction potential.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多种族人群样本中的胰腺癌遗传风险因素分析
背景:胰腺癌(PC)是所有癌症中死亡率和发病率比值最高的癌症之一。及早发现高危人群,就能及早诊断。全基因组关联研究显示,在多种族人群中,一些基因变异与胰腺癌风险有关。我们的目的是在科威特的人口样本中研究这些基因变异与 PC 的关联:我们使用了来自 103 例胰腺导管腺癌(PDAC)标本和 132 例健康对照的 DNA 样本,对 ABO rs505922、BCAR1 rs7190458、LINC-PINT rs6971499、HNF1B rs4795218、VDR rs2228570、LINC-PINT rs6971499 和 HNF1B rs4795218 进行了基因分型、VDR rs2228570 rs731236、PRSS1 rs111033565 rs111033568 rs387906698 和 rs267606982 的基因分型,并通过免疫细胞化学法检测 VDR 的表达。结果ABO rs505922C和VDR rs2228570A与PDAC风险相关(几率比(OR):1.55,95%置信区间(CI):1.07 - 2.24,P = 0.027;OR:1.64,95% CI:1.09 - 2.48,P = 0.024;分别)。非加权多基因风险评分(ABO rs505922、BCAR1 rs7190458、LINC-PINT rs6971499和HNF1B rs4795218)与PDAC风险显著相关(β:-0.11,95% CI:-0.15至-0.05,P<0.001)。无论VDR单倍型如何,大多数PDAC标本中VDR表达下调或缺失:结论:ABO rs505922C 和 VDR rs2228570A 是我国人群中的 PDAC 遗传风险因素。种族会影响已报道的 PDAC 遗传风险因素的关联性,在进行 PDAC 遗传风险评估时应加以调整。有必要在其他种族人群中调查这些遗传风险因素,以评估其预测 PDAC 风险的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.10
自引率
15.40%
发文量
37
期刊介绍: World Journal of Oncology, bimonthly, publishes original contributions describing basic research and clinical investigation of cancer, on the cellular, molecular, prevention, diagnosis, therapy and prognosis aspects. The submissions can be basic research or clinical investigation oriented. This journal welcomes those submissions focused on the clinical trials of new treatment modalities for cancer, and those submissions focused on molecular or cellular research of the oncology pathogenesis. Case reports submitted for consideration of publication should explore either a novel genomic event/description or a new safety signal from an oncolytic agent. The areas of interested manuscripts are these disciplines: tumor immunology and immunotherapy; cancer molecular pharmacology and chemotherapy; drug sensitivity and resistance; cancer epidemiology; clinical trials; cancer pathology; radiobiology and radiation oncology; solid tumor oncology; hematological malignancies; surgical oncology; pediatric oncology; molecular oncology and cancer genes; gene therapy; cancer endocrinology; cancer metastasis; prevention and diagnosis of cancer; other cancer related subjects. The types of manuscripts accepted are original article, review, editorial, short communication, case report, letter to the editor, book review.
期刊最新文献
Analysis of Pancreatic Cancer Genetic Risk Factors in a Multi-Ethnic Population Sample. Assessment of Five-Year Relative Survival of Patients With Endometrial Cancer: A Period Analysis. Correction to: Empowerment-Led Guided Self-Help Intervention for Symptom Burden in Breast Cancer Women Treated With Ovarian Function Suppression: A Randomized Trial Protocol. Cryotherapy in the Treatment of Early-Stage Breast Cancer. Multi-Gene Panel Testing for Hereditary Cancer Predisposition Among Patients Sixty-Five Years and Above Diagnosed With Breast Cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1